NCT02369068View on ClinicalTrials.gov

Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain

NACompletedINTERVENTIONAL
Enrollment

21

Participants

Timeline

Start Date

August 31, 2015

Primary Completion Date

March 26, 2018

Study Completion Date

September 24, 2018

Conditions
Pelvic Pain
Interventions
DRUG

Onabotulinumtoxin A

Intravaginal pelvic floor injection one series

DRUG

Kenalog

Intravaginal pelvic floor injection one series

Trial Locations (1)

48073

Beaumont Hospitals, Royal Oak

All Listed Sponsors
lead

Jamie Bartley, DO

OTHER

NCT02369068 - Onabotulinumtoxin A Versus Kenalog for Chronic Pelvic Pain | Biotech Hunter | Biotech Hunter